Robots Making Precision Medicines
Our robots help the life science industry make precision medicines for all patients.
We believe in a world where every patient has access to next-gen, precision medicines.
Multiply Labs’ robotic technology is the gold standard for the manufacturing of these life-saving products.
Fred Parietti, Ph.D.
Co-Founder & CEO
Fred holds a PhD in robotics from MIT and has extensive experience in the design of autonomous robotic systems (awarded with the MIT Mechanical Engineering De Florez Design Award). Before MIT, Fred worked on advanced robotics at Carnegie Mellon University, the Polytechnic University of Milan (Italy) and ETH Zurich (Switzerland). Fred has authored or co-authored 16 peer-reviewed scientific publications, which have been cited more than 1,500 times. He is also a co-inventor in 10 patents and patent applications.
$20 Million Series A is led by Casdin Capital, with participation from Lux Capital and Pathfinder, Founders Fund’s early stage investment vehicle to support the deployment of cloud-controlled robotic systems to enable drug production at industrial scale.